Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
STAT3 Transcription Factor | 3 | 2022 | 874 | 1.040 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2023 | 644 | 0.690 |
Why?
|
Pericytes | 1 | 2022 | 291 | 0.680 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1971 | 0.630 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2022 | 428 | 0.600 |
Why?
|
Kidney | 8 | 2023 | 7183 | 0.560 |
Why?
|
Ear | 1 | 2015 | 173 | 0.510 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2015 | 79 | 0.500 |
Why?
|
Gryllidae | 2 | 2023 | 18 | 0.470 |
Why?
|
Fibrinogen | 3 | 2014 | 894 | 0.450 |
Why?
|
Cyclin-Dependent Kinase 5 | 2 | 2010 | 112 | 0.440 |
Why?
|
Kidney Diseases | 5 | 2016 | 2147 | 0.430 |
Why?
|
Fibrosis | 6 | 2023 | 2029 | 0.410 |
Why?
|
Reperfusion Injury | 3 | 2013 | 1026 | 0.400 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2208 | 0.380 |
Why?
|
Interleukins | 3 | 2022 | 791 | 0.360 |
Why?
|
Receptors, Virus | 1 | 2013 | 648 | 0.360 |
Why?
|
Adipocytes | 1 | 2015 | 1182 | 0.330 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 229 | 0.330 |
Why?
|
Amide Synthases | 1 | 2007 | 12 | 0.310 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.300 |
Why?
|
Electrochemistry | 1 | 2007 | 145 | 0.300 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2948 | 0.290 |
Why?
|
Alcohol Dehydrogenase | 1 | 2007 | 119 | 0.290 |
Why?
|
Protein Kinases | 1 | 2013 | 1639 | 0.280 |
Why?
|
Heterozygote | 1 | 2012 | 2805 | 0.270 |
Why?
|
MicroRNAs | 4 | 2023 | 3747 | 0.250 |
Why?
|
Nanodiamonds | 1 | 2023 | 2 | 0.240 |
Why?
|
Carboplatin | 4 | 2008 | 800 | 0.240 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2022 | 835 | 0.230 |
Why?
|
Asparagine | 1 | 2023 | 122 | 0.220 |
Why?
|
Bystander Effect | 2 | 2015 | 81 | 0.220 |
Why?
|
Membrane Glycoproteins | 1 | 2013 | 3769 | 0.210 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 17 | 0.210 |
Why?
|
Graphite | 1 | 2022 | 66 | 0.210 |
Why?
|
Stem Cells | 1 | 2015 | 3567 | 0.210 |
Why?
|
Apoptosis | 6 | 2017 | 9728 | 0.210 |
Why?
|
Mitomycin | 2 | 2015 | 259 | 0.210 |
Why?
|
Smad7 Protein | 2 | 2019 | 41 | 0.210 |
Why?
|
Cell Cycle | 1 | 2010 | 2967 | 0.200 |
Why?
|
Cell Transdifferentiation | 1 | 2022 | 171 | 0.190 |
Why?
|
Biosensing Techniques | 1 | 2007 | 668 | 0.190 |
Why?
|
Ethanol | 1 | 2007 | 1342 | 0.190 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2022 | 625 | 0.180 |
Why?
|
Arthritis, Experimental | 1 | 2022 | 291 | 0.170 |
Why?
|
Mice, Knockout | 6 | 2022 | 14556 | 0.170 |
Why?
|
Polycystic Kidney Diseases | 1 | 2020 | 133 | 0.170 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2020 | 168 | 0.170 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2022 | 1372 | 0.160 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 191 | 0.150 |
Why?
|
Animals | 25 | 2023 | 168788 | 0.150 |
Why?
|
Mice, Inbred C57BL | 9 | 2022 | 21824 | 0.140 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2023 | 1337 | 0.140 |
Why?
|
Oncogene Protein p21(ras) | 1 | 2016 | 82 | 0.140 |
Why?
|
Rats, Wistar | 3 | 2018 | 1903 | 0.140 |
Why?
|
Mice, Inbred BALB C | 5 | 2021 | 6386 | 0.140 |
Why?
|
Drug Design | 2 | 2018 | 1078 | 0.140 |
Why?
|
Mice | 16 | 2023 | 81178 | 0.130 |
Why?
|
Macrophages | 4 | 2019 | 5657 | 0.130 |
Why?
|
Lupus Nephritis | 1 | 2019 | 310 | 0.130 |
Why?
|
Autoimmunity | 2 | 2022 | 1349 | 0.130 |
Why?
|
Toxicity Tests | 1 | 2015 | 121 | 0.130 |
Why?
|
DNA Damage | 4 | 2022 | 2432 | 0.130 |
Why?
|
Cell Death | 2 | 2019 | 1708 | 0.130 |
Why?
|
Longevity | 1 | 2022 | 1069 | 0.130 |
Why?
|
Cysts | 1 | 2020 | 679 | 0.130 |
Why?
|
Autophagy | 1 | 2023 | 1300 | 0.130 |
Why?
|
Primary Graft Dysfunction | 1 | 2015 | 93 | 0.120 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.120 |
Why?
|
Cell Survival | 4 | 2019 | 5881 | 0.120 |
Why?
|
Environmental Pollutants | 1 | 2023 | 1180 | 0.120 |
Why?
|
Diabetic Nephropathies | 1 | 2021 | 985 | 0.120 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 783 | 0.120 |
Why?
|
Th17 Cells | 2 | 2022 | 766 | 0.110 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3921 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1808 | 0.110 |
Why?
|
RNA, Messenger | 4 | 2018 | 13036 | 0.110 |
Why?
|
Heme Oxygenase-1 | 1 | 2015 | 381 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2214 | 0.110 |
Why?
|
Inflammation | 3 | 2022 | 10634 | 0.110 |
Why?
|
RNA, Small Interfering | 4 | 2021 | 3505 | 0.110 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.100 |
Why?
|
Phosphorylation | 3 | 2013 | 8437 | 0.100 |
Why?
|
Nanoparticles | 1 | 2023 | 1905 | 0.100 |
Why?
|
Fluorouracil | 2 | 2007 | 1616 | 0.100 |
Why?
|
Protein Biosynthesis | 2 | 2016 | 2126 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2019 | 0.100 |
Why?
|
Fluorescent Antibody Technique | 2 | 2012 | 2505 | 0.090 |
Why?
|
Glucose Transporter Type 4 | 1 | 2010 | 250 | 0.090 |
Why?
|
Bayes Theorem | 1 | 1998 | 2309 | 0.090 |
Why?
|
Intestines | 1 | 2019 | 1924 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 1998 | 1071 | 0.090 |
Why?
|
Coordination Complexes | 1 | 2011 | 115 | 0.090 |
Why?
|
Caveolin 1 | 1 | 2011 | 264 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2594 | 0.080 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2011 | 426 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4252 | 0.080 |
Why?
|
Copper | 1 | 2011 | 366 | 0.080 |
Why?
|
Protein Binding | 3 | 2022 | 9392 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 2988 | 0.080 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1950 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13668 | 0.080 |
Why?
|
DNA Primers | 1 | 2012 | 2892 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 625 | 0.080 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2013 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3079 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.070 |
Why?
|
Blotting, Western | 2 | 2012 | 5180 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1903 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 164 | 0.070 |
Why?
|
Receptor, Insulin | 1 | 2010 | 846 | 0.070 |
Why?
|
Signal Transduction | 4 | 2023 | 23404 | 0.070 |
Why?
|
Electric Conductivity | 1 | 2007 | 411 | 0.070 |
Why?
|
Adjuvants, Pharmaceutic | 1 | 2006 | 50 | 0.070 |
Why?
|
Kidney Tubules, Proximal | 2 | 2021 | 416 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2006 | 64 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3712 | 0.070 |
Why?
|
Plasmids | 1 | 2011 | 2307 | 0.070 |
Why?
|
Cells, Cultured | 5 | 2021 | 19227 | 0.060 |
Why?
|
Cell Line | 2 | 2023 | 15999 | 0.060 |
Why?
|
Kidney Tubules | 2 | 2019 | 488 | 0.060 |
Why?
|
Papillomaviridae | 2 | 2011 | 1119 | 0.060 |
Why?
|
Base Sequence | 2 | 2015 | 12801 | 0.060 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 868 | 0.060 |
Why?
|
Humans | 28 | 2023 | 744220 | 0.060 |
Why?
|
Cell Proliferation | 6 | 2019 | 10480 | 0.060 |
Why?
|
Rats | 3 | 2018 | 24273 | 0.060 |
Why?
|
Antitubercular Agents | 1 | 2012 | 1320 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2023 | 9735 | 0.060 |
Why?
|
Tumor Microenvironment | 1 | 2015 | 3584 | 0.060 |
Why?
|
Databases, Factual | 1 | 1998 | 7730 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4465 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2022 | 11478 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3085 | 0.050 |
Why?
|
Coumarins | 1 | 2022 | 119 | 0.050 |
Why?
|
Disease Progression | 3 | 2019 | 13280 | 0.050 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2022 | 180 | 0.050 |
Why?
|
Cell Line, Tumor | 7 | 2018 | 16687 | 0.050 |
Why?
|
Interleukin-17 | 2 | 2021 | 900 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8037 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5169 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3772 | 0.050 |
Why?
|
Caco-2 Cells | 1 | 2022 | 387 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2022 | 188 | 0.050 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2021 | 33 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2021 | 55 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3523 | 0.050 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2022 | 365 | 0.050 |
Why?
|
Palmitic Acid | 1 | 2021 | 154 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 379 | 0.050 |
Why?
|
Serum Albumin, Bovine | 1 | 2021 | 324 | 0.050 |
Why?
|
Molecular Conformation | 2 | 2012 | 563 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2010 | 2183 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2015 | 4251 | 0.040 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2022 | 414 | 0.040 |
Why?
|
TRPP Cation Channels | 1 | 2020 | 176 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 709 | 0.040 |
Why?
|
Neoplasms | 3 | 2018 | 21672 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12075 | 0.040 |
Why?
|
RNA Interference | 2 | 2021 | 2890 | 0.040 |
Why?
|
Pyridines | 1 | 2011 | 2822 | 0.040 |
Why?
|
Diethylnitrosamine | 1 | 2018 | 38 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 507 | 0.040 |
Why?
|
Plaque, Amyloid | 1 | 2023 | 729 | 0.040 |
Why?
|
Tuberculosis | 1 | 2012 | 1912 | 0.040 |
Why?
|
Oncogene Protein v-akt | 2 | 2011 | 135 | 0.040 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2019 | 159 | 0.040 |
Why?
|
Equipment Design | 1 | 2007 | 3582 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5096 | 0.040 |
Why?
|
Sulfones | 1 | 2021 | 437 | 0.040 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 110 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 186 | 0.040 |
Why?
|
Th1 Cells | 1 | 2022 | 1057 | 0.040 |
Why?
|
Structure-Activity Relationship | 1 | 2023 | 3133 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
Cilia | 1 | 2020 | 466 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8426 | 0.030 |
Why?
|
Leupeptins | 1 | 2015 | 122 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1456 | 0.030 |
Why?
|
HeLa Cells | 2 | 2015 | 3129 | 0.030 |
Why?
|
Benzamides | 1 | 2021 | 1378 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2007 | 3461 | 0.030 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2015 | 87 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2009 | 731 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2007 | 1587 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 217 | 0.030 |
Why?
|
Ancrod | 1 | 2014 | 7 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2375 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1266 | 0.030 |
Why?
|
Kinetics | 1 | 2023 | 6474 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2021 | 1121 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3203 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2088 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 643 | 0.030 |
Why?
|
Chemokines | 1 | 2019 | 969 | 0.030 |
Why?
|
DNA | 2 | 2023 | 7303 | 0.030 |
Why?
|
Species Specificity | 1 | 2019 | 2480 | 0.030 |
Why?
|
Smad2 Protein | 1 | 2014 | 156 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2503 | 0.030 |
Why?
|
beta Catenin | 1 | 2018 | 1059 | 0.030 |
Why?
|
DNA Repair | 1 | 2022 | 2046 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 392 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2108 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9582 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1170 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5475 | 0.030 |
Why?
|
PPAR gamma | 1 | 2015 | 493 | 0.030 |
Why?
|
Ureteral Obstruction | 1 | 2014 | 293 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18027 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5853 | 0.030 |
Why?
|
Male | 8 | 2021 | 350027 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1423 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14726 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2008 | 3701 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2011 | 212 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3506 | 0.020 |
Why?
|
Trigonella | 1 | 2010 | 3 | 0.020 |
Why?
|
Cytochalasin B | 1 | 2010 | 74 | 0.020 |
Why?
|
DNA Cleavage | 1 | 2011 | 58 | 0.020 |
Why?
|
Insulin Antagonists | 1 | 2010 | 20 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1877 | 0.020 |
Why?
|
Genistein | 1 | 2010 | 84 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4187 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2220 | 0.020 |
Why?
|
Microscopy, Video | 1 | 2010 | 245 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2023 | 3585 | 0.020 |
Why?
|
Mice, SCID | 1 | 2015 | 2716 | 0.020 |
Why?
|
Receptors, Death Domain | 1 | 2009 | 32 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 118 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 20817 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1525 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 1434 | 0.020 |
Why?
|
Edetic Acid | 1 | 2009 | 276 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2634 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2008 | 222 | 0.020 |
Why?
|
Androstadienes | 1 | 2010 | 346 | 0.020 |
Why?
|
Cricetulus | 1 | 2010 | 817 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2007 | 19907 | 0.020 |
Why?
|
Adipokines | 1 | 2011 | 319 | 0.020 |
Why?
|
Obesity | 1 | 2011 | 12742 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 5021 | 0.020 |
Why?
|
CHO Cells | 1 | 2010 | 1407 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 561 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 908 | 0.020 |
Why?
|
Plant Extracts | 1 | 2010 | 472 | 0.020 |
Why?
|
Cricetinae | 1 | 2010 | 2472 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4201 | 0.020 |
Why?
|
Female | 9 | 2018 | 380197 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2011 | 2012 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2008 | 905 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6116 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1341 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10949 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1854 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2007 | 441 | 0.020 |
Why?
|
Protein Transport | 1 | 2010 | 1989 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2010 | 1971 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7472 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2014 | 3201 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2700 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2007 | 640 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5892 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3690 | 0.010 |
Why?
|
Ligands | 1 | 2009 | 3294 | 0.010 |
Why?
|
Up-Regulation | 1 | 2011 | 4217 | 0.010 |
Why?
|
Time Factors | 1 | 2023 | 40063 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7799 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2292 | 0.010 |
Why?
|
Drug Combinations | 1 | 2006 | 1962 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1782 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3305 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3748 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4752 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13817 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 3001 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2010 | 2875 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18116 | 0.010 |
Why?
|
NF-kappa B | 1 | 2006 | 2501 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23337 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6583 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57768 | 0.010 |
Why?
|
Aged | 2 | 2018 | 163253 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 213367 | 0.010 |
Why?
|
Adult | 1 | 2018 | 214035 | 0.000 |
Why?
|